Shape Memory Medical (SMM) is a California-based medical device company focused on developing endovascular therapies built on its proprietary Shape Memory Polymer (SMP) technology. The company addresses unmet clinical needs in peripheral vascular embolization, abdominal aortic aneurysm (AAA), and aortic dissection through innovative minimally invasive solutions. As the first company to successfully commercialize Shape Memory Polymer technology for endovascular applications, SMM's products are designed to expand after catheter delivery, conform to complex vascular anatomy, and promote stable embolization and tissue healing while minimizing metal burden and imaging artifacts. The company has received U.S. FDA clearance for multiple commercial products and continues to advance a robust pipeline through global clinical trials, with the goal of becoming a global leader in next-generation polymer-based endovascular therapies.